| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13276* | 2021 |
| Tumor-repopulating cells induce PD-1 expression in CD8+ T cells by transferring kynurenine and AhR activation Y Liu, X Liang, W Dong, Y Fang, J Lv, T Zhang, R Fiskesund, J Xie, J Liu, ... Cancer cell 33 (3), 480-494. e7, 2018 | 391 | 2018 |
| ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth S Zhang, L Chen, B Cui, HY Chuang, J Yu, J Wang-Rodriguez, L Tang, ... PloS one 7 (3), e31127, 2012 | 295 | 2012 |
| MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia B Cui, L Chen, S Zhang, M Mraz, JF Fecteau, J Yu, EM Ghia, L Zhang, ... Blood 124 (4), 546-54, 2014 | 255 | 2014 |
| The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers S Zhang, L Chen, J Wang-Rodriguez, L Zhang, B Cui, W Frankel, R Wu, ... The American Journal of Pathology 181 (6), 1903-1910, 2012 | 231 | 2012 |
| Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation J Yu, L Chen, B Cui, GF Widhopf, Z Shen, R Wu, L Zhang, S Zhang, ... The Journal of clinical investigation 126 (2), 585-598, 2016 | 208 | 2016 |
| Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy S Zhang, B Cui, H Lai, G Liu, EM Ghia, GF Widhopf, Z Zhang, CCN Wu, ... Proceedings of the National Academy of Sciences 111 (48), 17266-17271, 2014 | 199 | 2014 |
| Targeting ROR1 inhibits epithelial–mesenchymal transition and metastasis B Cui, S Zhang, L Chen, J Yu, GF Widhopf, JF Fecteau, LZ Rassenti, ... Cancer research 73 (12), 3649-3660, 2013 | 190 | 2013 |
| TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury HZ Yang, JP Wang, SU Mi, HZ Liu, B Cui, HM Yan, J Yan, Z Li, H Liu, ... The American journal of pathology 180 (1), 275-292, 2012 | 170 | 2012 |
| TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription J Yu, W Sun, Z Wang, X Liang, F Hua, K Li, X Lv, X Zhang, Y Liu, J Yu, ... Nature communications 10 (1), 5720, 2019 | 161 | 2019 |
| High-level ROR1 associates with accelerated disease-progression in chronic lymphocytic leukemia B Cui, EM Ghia, L Chen, LZ Rassenti, C DeBoever, GF Widhopf, J Yu, ... Blood 128 (25), 2931-2940, 2016 | 145 | 2016 |
| TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations F Hua, K Li, JJ Yu, XX Lv, J Yan, XW Zhang, W Sun, H Lin, S Shang, ... Nature communications 6 (1), 7951, 2015 | 144 | 2015 |
| Pre-clinical specificity and safety of UC-961, a first-in-class monoclonal antibody targeting ROR1 MY Choi, GF Widhopf II, CCN Wu, B Cui, F Lao, A Sadarangani, ... Clinical Lymphoma Myeloma and Leukemia 15, S167-S169, 2015 | 132 | 2015 |
| TRIB3 interacts with β-catenin and TCF4 to increase stem cell features of colorectal cancer stem cells and tumorigenesis F Hua, S Shang, Y Yang, H Zhang, T Xu, J Yu, D Zhou, B Cui, K Li, X Lv, ... Gastroenterology 156 (3), 708-721. e15, 2019 | 131 | 2019 |
| Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44 S Zhang, CCN Wu, JF Fecteau, B Cui, L Chen, L Zhang, R Wu, L Rassenti, ... Proceedings of the National Academy of Sciences 110 (15), 6127-6132, 2013 | 128 | 2013 |
| Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment HZ Yang, B Cui, HZ Liu, ZR Chen, HM Yan, F Hua, ZW Hu The Journal of Immunology 182 (1), 692-702, 2009 | 123 | 2009 |
| ROR1 can interact with TCL1 and enhance leukemogenesis in Eµ-TCL1 transgenic mice GF Widhopf, B Cui, EM Ghia, L Chen, K Messer, Z Shen, SP Briggs, ... Proceedings of the National Academy of Sciences 111 (2), 793-798, 2014 | 117 | 2014 |
| Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation XW Zhang, JC Zhou, D Peng, F Hua, K Li, JJ Yu, XX Lv, B Cui, SS Liu, ... Autophagy 16 (5), 782-796, 2020 | 115 | 2020 |
| Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody S Zhang, H Zhang, EM Ghia, J Huang, L Wu, J Zhang, S Lam, Y Lei, J He, ... Proceedings of the National Academy of Sciences 116 (4), 1370-1377, 2019 | 112 | 2019 |
| Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21WAF1/Cip1-dependent mechanism independent of functional p53 JF Fecteau, LG Corral, EM Ghia, S Gaidarova, D Futalan, IS Bharati, ... Blood, The Journal of the American Society of Hematology 124 (10), 1637-1644, 2014 | 110 | 2014 |
Thomas J. KippsProfessor of Medicine, UC San Diego在 ucsd.edu 的电子邮件经过验证
